Lam Research Other Non-Current Liabilities decreased by 3.5% to $612.78M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.1%, from $546.67M to $612.78M. Over 4 years (FY 2021 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 9.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $398.73M | $466.00M | $466.83M | $450.48M | $422.94M | $418.76M | $496.36M | $512.38M | $501.29M | $482.98M | $511.43M | $516.68M | $575.01M | $574.13M | $533.70M | $546.67M | $581.61M | $623.93M | $635.21M | $612.78M |
| QoQ Change | — | +16.9% | +0.2% | -3.5% | -6.1% | -1.0% | +18.5% | +3.2% | -2.2% | -3.7% | +5.9% | +1.0% | +11.3% | -0.2% | -7.0% | +2.4% | +6.4% | +7.3% | +1.8% | -3.5% |
| YoY Change | — | — | — | — | +6.1% | -10.1% | +6.3% | +13.7% | +18.5% | +15.3% | +3.0% | +0.8% | +14.7% | +18.9% | +4.4% | +5.8% | +1.1% | +8.7% | +19.0% | +12.1% |